When was TeraPore founded?

TeraPore was founded in 2013 and raised its 1st funding round within a year of its incorporation.

Where is TeraPore located?

TeraPore is headquartered in San Francisco, United States.

Who is the current CEO of TeraPore?

Rachel Dorin of TeraPore. They have also founded 1 company.

How many employees does TeraPore have?

As of Sep 30, 2026, the latest employee count at TeraPore is 12.

Is TeraPore a funded company?

TeraPore is a funded company, having raised a total of $19.5M across 13 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 25, 2013.

When was the latest funding round of TeraPore?

TeraPore's latest funding was a $***** Series B round on Mar 02, 2023, with participation from 3 investors.

Where does TeraPore rank among its competitors?

TeraPore ranks 2nd amongst 22 active competitors, of which 3 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Tanda Biotech, which secured $75K in Feb, 2026.

Who are the top competitors of TeraPore?

TeraPore's top competitors include Cytosorbents, SANI Membranes and Szmeizhao. Among them, Tanda Biotech secured the most recent funding round in February, 2026.

TeraPore - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of bioseparation solutions for therapeutics and novel biologics. The company uses a proprietary Intelligent Membrane technology platform to develop "IsoBlock" filters which offer exceptional viral clearance with high filtration capacity for virus filtration applications.

Website: www.terapore.com/
Email ID: *****@teraporetech.com
Phone Number: +1 **********

Key Metrics

Founded Year

2013

Location

San Francisco, United States

Stage

Series B

Total Funding

$19.5M in 13 rounds

Latest Funding Round

Series B, Mar 02, 2023, $*****

Investors

Anzu Partners & 9 more

Ranked

2^nd among 22 active competitors

Employee Count

12 as on Sep 30, 2026

Similar Companies

Cytosorbents & 22 more

View TeraPore's full profile

TeraPore has raised a total funding of $19.5M over 13 rounds. Its first funding round was on Jun 25, 2013. Its latest funding round was a Series B round on Mar 02, 2023 for $*****. 3 investors participated in its latest round. TeraPore has 10 institutional investors.

Here is the list of recent funding rounds of TeraPore:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 02, 2023	4153542	Series B	8124082	9585970	2779694	2195172
Mar 06, 2018	3134860	Series A	3774391	1704336	3589955	RA Capital Management & 2 more
Dec 21, 2017	6675893	Seed	7562853	3762801	7333687	3119336

Access funding benchmarks and valuations. Sign up today!

View details of TeraPore's funding rounds and investors

The founders of TeraPore is Rachel Dorin. Rachel Dorin is the CEO of TeraPore.

Here are the details of TeraPore's key team members:

Rachel Dorin: Founder & CEO of TeraPore and founder of 1 other company.
Contact Info: 1 email address

View details of TeraPore's Founder profiles and Board Members

TeraPore's employee count trend

TeraPore has 12 employees as of Sep 26. Here is TeraPore's employee count trend over the years:

Uncover TeraPore's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TeraPore include Cytosorbents, SANI Membranes and Szmeizhao. Here is the list of Top 10 competitors of TeraPore, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cytosorbents 1997, Monmouth Junction (United States), Public	Developer of hemoperfusion technology for removing toxins from the blood	$22M	Western Alliance Bank, NJTC Venture Fund & 5 others	66/100
2nd	TeraPore 2013, San Francisco (United States), Series B	Developer of bioseparation solutions for therapeutics and novel biologics	$19.5M	RA Capital Management, Artiman & 8 others	46/100
3rd	SANI Membranes 2013, Vaerlose (Denmark), Unfunded	Developer of advanced filtration systems for bimolecular separation	-	-	31/100
4th	Szmeizhao 2002, Shenzhen (China), Funding Raised	Provider of integrated solutions for digital hospital environment and energy management	-	Dami Ventures, China Investment LuckyStone Management ... Read more	31/100
5th	Hermes Bioscience 2024, San Francisco (United States), Seed	Developer of benchtop extracellular vesicle isolation technology to purify exosomes	-	Genoa Ventures, Vertical Venture Partners ... & 1 others	29/100
6th	Membrana 1998, Charlotte (United States), Acquired	Manufacturer of filtration membranes for life sciences industries	-	-	28/100
7th	Filtravate 2020, Las Cruces (United States), Seed	Provider of ultrafiltration membranes for bioprocessing and pharmaceutical industries	$300K	VIC Technology Venture Development, National Science Foundation ... Read more	27/100
8th	Tanda Biotech 2023, Buffalo Grove (United States), Funding Raised	Developer of filtration technologies for biomanufacturing scalability and cost efficiency	-	Illinois Science Technology, National Science Foundation ... Read more	26/100
9th	Bioimmunate 2014, Jerusalem (Israel), Funding Raised	Developer of blood filtration devices for autoimmune diseases	-	K3, Sanfrance Capital	25/100
10th	Alkymos 2006, Lexington (United States), Deadpooled	Chelators and chelator-based filtration devices	$644K	Enterprise Angels Community Fund I, SBIR & 1 others	25/100